Potential risk of porcine-derived pancreatic enzyme medication for the cross-species transmission of hepatitis E virus

Gut. 2024 Sep 9;73(10):1599-1600. doi: 10.1136/gutjnl-2024-332577.

Authors

Nicola Frericks¹, Volker Kinast², Eike Steinmann^{3

4}

Affiliations

¹ Department of Molecular and Medical Virology, Ruhr University Bochum, Bochum, Germany.
² Department of Medical Microbiology and Virology, Carl von Ossietzky Universität Oldenburg, Oldenburg, Germany.
³ Department of Molecular and Medical Virology, Ruhr University Bochum, Bochum, Germany eike.steinmann@ruhr-uni-bochum.de.
⁴ German Centre for Infection Research (DZIF), External Partner Site, Bochum, Germany.

No abstract available

Keywords: CYSTIC FIBROSIS; HEPATITIS E.

Publication types

Letter

MeSH terms

Animals
Hepatitis E virus*
Hepatitis E* / drug therapy
Hepatitis E* / transmission
Humans
Pancreas / enzymology
Swine